Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Pharmexa licenses Biogen Idec's Provax adjuvant

Sep. 2, 2005

Belatacept found as effective and better tolerated than ciclosporin in renal transplant recipients

Sep. 1, 2005

MedImmune licenses rights from GSK to BSYX-A110

Sep. 1, 2005

Acambis on track to begin phase III trials of ChimeriVax-JE by year-end

Aug. 31, 2005

Acambis and VIB team up on flu vaccine development

Aug. 17, 2005

Halofuginone modulates T-cell functional activity

Aug. 16, 2005

European authorities approve phase III studies of Japanese encephalitis vaccine

Aug. 11, 2005

Novel immunomodulatory agents disclosed in recent patents

Aug. 9, 2005

KBMA vaccines: novel strategy for safe protective immunity

Aug. 9, 2005

Withdrawal of Infanrix HepB marketing authorization in Europe

Aug. 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...